ALFA Filings
Every announcement, straight from the exchange
Every earnings call announcement on NSE and BSE that our alert engine sent, newest first.
Time
7,037 announcements
Sportking India reported strong Q1 FY27 results with revenue of ₹703.7 Cr (up 20% YoY) and PAT of ₹76.0 Cr (up 123% YoY). The company is focusing on forward integration into fabrics and garments.
Ethos Limited delivered strong Q1 FY27 results with consolidated revenue of ₹461.7 Cr, up 33.3% YoY. Strategy focuses on luxury boutique expansion and high-margin exclusive brand scaling.
Aurionpro reported Q1 FY27 revenue of Rs. 358 Cr (up 6.3% YoY) and PAT of Rs. 45 Cr. Management is pivoting from MEA markets toward SE Asia and Europe while building an AI-native product stack.
TCI reports Q1 FY27 consolidated revenue of ₹12,548 Mn, up 9.1% YoY, with EBITDA at ₹1,599 Mn. Strategy focuses on 'Everything Logistics' via multimodal integration and digitization.
MobiKwik achieved three consecutive profitable quarters with Q1 FY27 PAT at ₹76 Mn. Strategy focuses on high-margin credit products and UPI user acquisition.
Tejas reported Q1 FY27 revenue of INR 402 Cr (up 20% QoQ) but a loss at PBT level of INR 271 Cr. Management is leveraging BSNL success to drive international 5G wins.
Vishnu Chemicals reported strong Q1FY27 results with 25% YoY revenue growth and 23% PAT growth, driven by a diversified domestic-to-export mix and strategic integration.
Park Medi World reports strong Q1 FY27 results with 19% YoY revenue growth and 35% PAT growth. Strategy focuses on North India cluster expansion through acquisitions and greenfield projects.
NALCO reported a strong Q1 FY26-27 with Revenue from Operations reaching ₹5,302 Cr and PAT at ₹2,002 Cr, driven by integrated operations and global market leadership.
Sarda Energy reported steady Q1 FY27 results with consolidated EBITDA of Rs. 762 Cr (9.4% YoY growth) and record PAT of Rs. 478 Cr, driven by the energy segment and a one-time tariff true-up.
3i Infotech reported Q1 FY27 operating revenue of ₹177.9 crore (4.3% YoY growth) and PAT of ₹6.5 crore. Focus is on AI-led operating models and 'Vision 2030' aspirations.
Sathlokhar reports robust Q1 FY27 results with total income reaching ₹206.19 Cr and PAT more than doubling. Strategy focuses on backward integration through a new PEB manufacturing facility.
Prataap Snacks delivered record Q1 FY27 revenue of ₹492 Cr, up 20% YoY. Strategy focuses on distribution expansion, quick commerce growth, and a 2-3% EBITDA margin improvement target.
Q1 FY27 results show 44% revenue growth to ₹528 Cr. Management is focusing on scaling 'InstaHelp' despite current losses, while the core India services and International segments are profitable.
NTPC reports robust FY26 performance with standalone PAT growing at 9.21% CAGR over FY22. Management is pivoting towards an integrated energy major, targeting 250GW capacity by 2037.
Persistent reported Q1 FY27 revenue of $452.4M (up 16.1% YoY) with an EBIT margin of 16.0%. Management announced a strategic merger with Nagarro.
Q1 FY27 revenue fell 9.2% YoY to ₹256 Cr with 15.4% EBITDA margin. Focus remains on Technicals (71% revenue share) and export expansion.
Muthoot Finance posted robust 43% YoY loan growth but faced a significant 300 bps yield compression due to strategic pricing and high-base effect.
Utkarsh SFB Q1FY27 results were impacted by MFI market disruptions, reporting a PAT loss of ₹34 Cr. Strategy focuses on shifting to a diversified, 51% secured asset mix.
Concord Biotech reported strong Q1FY27 consolidated performance with 26% revenue growth and 31% PAT growth, driven by a 46% surge in exports and expanding market share in niche fermentation APIs.
Aditya Birla Lifestyle Brands delivered double-digit growth in Q1 FY27, with Revenue up 11% and PAT up 21% YoY. Strategy focuses on premiumization, omnichannel expansion, and scaling emerging brands.
Q1 FY27 results show a return to positive PBT of ₹0.14 Cr on 18.8% YoY revenue growth. Strategy focuses on gross margin expansion and inventory optimization.
Neogen reported robust Q1 FY27 results with 34% revenue growth and 53% EBITDA growth. Strategy pivots toward battery materials and organo-lithium, supported by a ₹600 crore QIP for de-leveraging.
Archean reported Q1FY27 consolidated revenue of ₹3,328 Mn, up 11% YoY. Strategy focuses on bromine derivatives, semiconductors via SiCSem, and energy storage through Offgrid Energy Labs.
Clean Science reports record consolidated sales driven by the HALS segment scaling up, though legacy business faced raw material supply disruptions. Management is aggressively pivoting toward high-margin, advanced HALS chemistry via a new Swiss strategic collaboration.
City Union Bank reported strong 1QFY27 results with 25% PAT growth to ₹383 Cr and 24% interest income growth. Focus remains on secured lending, particularly MSME and Gold Loans, maintaining industry-leading asset quality.
Exide Q1 FY27 revenue grew 17.6% YoY to Rs. 5,305 Cr, with PAT up 27.1% to Rs. 407 Cr. Management is pivoting from lead-acid leadership to a major lithium-ion expansion.
Aarti Drugs reported Q1FY27 revenue of ₹703.6 Cr with 19% YoY growth. EBITDA rose 30% to ₹96.9 Cr, driven by volume growth and improved pricing realizations across API and Specialty Chemicals portfolios.
SMS Pharma reported Q1FY27 revenue of ₹207 Cr (+6% YoY) with stable EBITDA margins at ~20%. Strategy focuses on high-value APIs and peptide R&D.
LatentView reports Q1FY27 revenue of $30.3Mn (up 9.9% YoY) with an Adjusted EBITDA margin of 20.4%. Strategy focuses on Data engineering (Databricks) and embedding AI across business lines.